BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17940219)

  • 1. Distinct receptor repertoire formation in mouse NK cell subsets regulated by MHC class I expression.
    Hayakawa Y; Watt SV; Takeda K; Smyth MJ
    J Leukoc Biol; 2008 Jan; 83(1):106-11. PubMed ID: 17940219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of NK cell receptor repertoire in adult and neonatal mice.
    Kubota A; Kubota S; Lohwasser S; Mager DL; Takei F
    J Immunol; 1999 Jul; 163(1):212-6. PubMed ID: 10384118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
    Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
    Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
    Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
    J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets.
    Toomey JA; Salcedo M; Cotterill LA; Millrain MM; Chrzanowska-Lightowlers Z; Lawry J; Fraser K; Gays F; Robinson JH; Shrestha S; Dyson PJ; Brooks CG
    J Immunol; 1999 Sep; 163(6):3176-84. PubMed ID: 10477585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules.
    Corral L; Hanke T; Vance RE; Cado D; Raulet DH
    Eur J Immunol; 2000 Mar; 30(3):920-30. PubMed ID: 10741410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo developmental stages in murine natural killer cell maturation.
    Kim S; Iizuka K; Kang HS; Dokun A; French AR; Greco S; Yokoyama WM
    Nat Immunol; 2002 Jun; 3(6):523-8. PubMed ID: 12006976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma?
    Graham CM; Christensen JR; Thomas DB
    Immunology; 2007 Jun; 121(2):238-47. PubMed ID: 17462078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity.
    Wang Y; Xu H; Zheng X; Wei H; Sun R; Tian Z
    Cell Mol Immunol; 2007 Oct; 4(5):377-82. PubMed ID: 17976318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taking license with natural killer cell maturation and repertoire development.
    Parham P
    Immunol Rev; 2006 Dec; 214():155-60. PubMed ID: 17100883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous CD27 triggering in vivo strongly reduces NK cell numbers.
    De Colvenaer V; Taveirne S; Hamann J; de Bruin AM; De Smedt M; Taghon T; Vandekerckhove B; Plum J; van Lier R; Leclercq G
    Eur J Immunol; 2010 Apr; 40(4):1107-17. PubMed ID: 20140903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of natural killer cells: underlying molecular mechanisms revealed.
    Backström E; Kristensson K; Ljunggren HG
    Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
    J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase.
    Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL
    Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational modeling of human natural killer cell development suggests a selection process regulating coexpression of KIR with CD94/NKG2A.
    Salmon-Divon M; Höglund P; Johansson MH; Johansson S; Mehr R
    Mol Immunol; 2005 Feb; 42(4):397-403. PubMed ID: 15607790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow receptor acquisition by NK cells regenerated in vivo from transplanted fetal liver or adult bone marrow stem cells.
    Maeda M; Uchida N; Eaves CJ; Takei F
    Exp Hematol; 2003 Nov; 31(11):1015-8. PubMed ID: 14585363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere length in human natural killer cell subsets.
    Ouyang Q; Baerlocher G; Vulto I; Lansdorp PM
    Ann N Y Acad Sci; 2007 Jun; 1106():240-52. PubMed ID: 17303822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of human natural killer cell receptors in early life.
    Sundström Y; Nilsson C; Lilja G; Kärre K; Troye-Blomberg M; Berg L
    Scand J Immunol; 2007; 66(2-3):335-44. PubMed ID: 17635811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.